About (S)-4-ETHYL-4-HYDROXY-7 8-DIHYDRO-1H-PYRANO 3 4-F INDOLIZINE-3 6 10(4H)-TRIONE (CAS NO.110351-94-5)
. Our skilled professionals formulate these compounds by making use of various ingredients and chemicals available in the market. We formulate these drugs in our using latest equipment therefore these medicines have longer shelf life and are very effective. The(S)-4-Ethyl-4-hydroxy-7,8-Dihydro-1H-pyrano[3,4-F]indolizine-3,6,10(4H)-Trioneis available in various specifications to meet our clients demands.
Other details:
CAS NO.: 110351-94-5
Molecular Formula: C13H13NO5
Molecular Weight: 263.25
Pharmaceutical Grade IntermediateThis compound is highly valued in the pharmaceutical industry for its superior purity and consistency. It acts as an essential intermediate in the synthesis of advanced drug formulations and supports a wide range of research and development processes. Its well-defined chemical structure provides reliability and facilitates stringent quality control measures during manufacturing.
Trusted Supply Chain from ChinaWith China being a major hub for chemical manufacturing, the product is readily available through reputable distributors, exporters, manufacturers, suppliers, and traders. This ensures a stable and timely delivery for both small-scale laboratories and large pharmaceutical production facilities, helping streamline project timelines and facilitate global pharmaceutical advancements.
FAQs of (S)-4-ETHYL-4-HYDROXY-7 8-DIHYDRO-1H-PYRANO 3 4-F INDOLIZINE-3 6 10(4H)-TRIONE (CAS NO.110351-94-5):
Q: How is (S)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione typically used in the pharmaceutical industry?
A: This intermediate is primarily utilized in the synthesis of complex pharmaceutical compounds. Its reliable purity and chemical stability make it suitable for developing new drugs and active pharmaceutical ingredients during both research and production phases.
Q: What benefits does its high purity (99%) provide for pharmaceutical applications?
A: High purity ensures minimal interference from contaminants, which is crucial for creating safe and effective pharmaceutical products. It allows for precise formulation, improved reproducibility, and enhanced reliability in chemical reactions used in drug development.
Q: When should this compound be considered during pharmaceutical manufacturing?
A: This compound is best incorporated during the intermediate stages of pharmaceutical synthesis, particularly when building complex molecular structures necessary for targeted drug activity and efficacy.
Q: Where can this compound be sourced, and who are the trusted suppliers?
A: (S)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione is widely available from distributors, exporters, manufacturers, suppliers, and traders in China, known for their adherence to stringent quality and supply standards.
Q: What is the process for integrating this intermediate into pharmaceutical formulations?
A: Integration involves carefully measured incorporation during chemical synthesis, followed by rigorous quality assessments. Its powdered form allows for easy handling and blending in laboratory and industrial settings.
Q: How does its unique molecular formula contribute to its functionality as an intermediate?
A: The molecular formula C13H13NO5 offers functional groups that participate effectively in multi-step synthesis, enabling the creation of a broad range of pharmaceutical structures.
Q: Are there any notable usage advantages for researchers and manufacturers?
A: Its consistency, quality, and easy availability support efficient research workflows and scaled production, minimizing delays and enabling innovative pharmaceutical development.